TY  - JOUR
AU  - Ascaso del Río, Ana
AU  - García Pérez, Javier
AU  - Pérez Olmeda, Mayte
AU  - Arana Arri, Eunate
AU  - Vergara, Itziar
AU  - Pérez Ingidua, Carla
AU  - Bermejo, Mercedes
AU  - Castillo de la Osa, María
AU  - Imaz Ayo, Natale
AU  - Riaño Fernández, Ioana
AU  - Astasio González, Oliver
AU  - Díez Fuertes, Francisco
AU  - Mejide, Susana
AU  - Arrizabalaga, Julio
AU  - Hernández Gutiérrez, Lourdes
AU  - De la Torre Tarazona, Humberto Erick
AU  - Lázaro, Alberto Mariano 
AU  - Vargas Castrillón, Emilio
AU  - Alcamí, José
AU  - Portolés Pérez, Antonio
PY  - 2022
DO  - 10.1016/j.eclinm.2022.101542
SN  - 2589-5370
UR  - https://hdl.handle.net/20.500.14352/116012
T2  - eClinicalMedicine
AB  - Background There is no evidence to date on immunogenic response among individuals who participated in clinical trials of COVID-19 experimental vaccines redirected to standard national vaccination regimens.Methods This multicentre, prospective...
LA  - eng
PB  - Elsevier
KW  - COVID-19 vaccines
KW  - mRNA vaccines
KW  - Heterologous vaccination
KW  - BNT162b2
KW  - CVnCoV
KW  - Fourth dose
KW  - Neutralizing antibodies
KW  - Boost doses of vaccines
KW  - Omicron Experimental vaccines
KW  - Antibodies Immune response
TI  - Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study.
TY  - journal article
VL  - 51
ER  -